Current clinical trials of BAY 43-9006, part 2

ONCOLOGY

Volumn 19, Issue 6, 2005, Pages

  Wright, John J ^a   Zerivitz, Ken ^b   Gravell, Amy ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Technical Resources International Inc   (United States)

^c EMMES CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; DOXORUBICIN; GEMCITABINE; OXALIPLATIN; PACLITAXEL; SORAFENIB;

ANEMIA; CLINICAL TRIAL; COLORECTAL CANCER; DIARRHEA; FATIGUE; HAND FOOT SYNDROME; HEADACHE; HUMAN; HYPERTENSION; KIDNEY CARCINOMA; LEUKOPENIA; MELANOMA; NAUSEA; NEPHRECTOMY; NEUTROPENIA; PANCREAS CANCER; RASH; REVIEW; SENSORY NEUROPATHY; SKIN TOXICITY; SOLID TUMOR; STOMACH CANCER; THROMBOCYTOPENIA;

EID: 28444483873     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (9)

1. Carter C, Wessler C, Gellert J, et al (eds): Investigator's Brochure, version 5. West Haven, Conn, Bayer Pharmaceuticals Corp, 2004.
2. Ratain M, Flaherty K, Stadler W, et al: Preliminary antitumor activity of BAY 43-9006 in metastatic renal cell carcinoma and other advanced refractory solid tumors in a phase II randomized discontinuation trial (RDT) (abstract 4501). Proc Am Soc Clin Oncol 23:381, 2004.
3. Ahmad T, Eisen T: Kinase inhibition with BAY 43-9006 in renal cell carcinoma. Clin Cancer Res 10:6388S-6392S, 2004.
4. Ahmad T, Marais R, Pyle L, et al: BAY 43-9006 in patients with advanced melanoma: The Royal Marsden experience (abstract 7506). Proc Am Soc Clin Oncol 23:708, 2004.
5. Flaherty K, Brose M, Schuchter L, et al: Phase I/II trial of BAY 43-9006, carboplatin (C) and paclitaxel (P) demonstrates preliminary antitumor activity in the expansion cohort of patients with metastatic melanoma (abstract 7507). Proc Am Soc Clin Oncol 23:708, 2004.
6. Richly H, Kupsch P, Passarge K, et al: Results of a phase I trial of BAY 43-9006 in combination with doxorubicin in patients with refractory solid tumors (abstract 3049). Proc Am Soc Clin Oncol 23:207, 2004.
7. Kupsch P, Passarge K, Richly H, et al: Results of a phase I trial of BAY 43-9006 in combination with oxaliplatin in patients with refractory solid tumors (abstract 3056). Proc Am Soc Clin Oncol 23:209, 2004.
8. Siu L, Takimoto CH, Awada A, et al: A phase I/II trial of BAY 43-9006 and gemcitabine in advanced solid tumors and in advanced pancreatic cancer (abstract 3059). Proc Am Soc Clin Oncol 23:209, 2004.
9. Crump M, Leber B, Kassis J, et al: A randomized phase I clinical and biologic study of two schedules of BAY 43-9006 in patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML): A National Cancer Institute of Canada study (abstract 6611). Proc Am Soc Clin Oncol 23:583, 2004.